Can a skin injection of ketamine and lidocaine tame CRPS pain?

NCT ID NCT04650074

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether injecting a mix of ketamine and lidocaine into the skin, a technique called mesotherapy, can reduce neuropathic pain in people with complex regional pain syndrome type 1 (CRPS1). Participants receive four sessions of either the drug mixture or lidocaine alone. The study measures pain levels and other symptoms to see if this approach offers a new way to manage this difficult condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A mixture of ketamine and lidocaine injected into the skin via mesotherapy
What this could lead to
If effective, this approach could offer a new, well-tolerated way to manage chronic neuropathic pain in CRPS1, potentially reducing reliance on systemic medications.
What could go wrong
This is a small pilot study, and results may not be conclusive or generalizable. The treatment's effectiveness and safety are not yet established, and mesotherapy carries risks like injection-site reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COMPLEX REGIONAL PAIN SYNDROME TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of orthopedic surgery and trauma emergencies of the lower limb, Edouard Herriot Hospital, Hospices Civils de Lyon

    Lyon, 69437, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.